Institute of Oncology Research (IOR) (@IOR_Bellinzona) / X
Team - Functional Cancer Genomics Lab
1st SAKK Translational Urogenital Cancer Meeting Award 2021
A Small Molecule that Binds and Inhibits the ETV1 Transcription Factor Oncoprotein
Malévoz (2017) - IMDb
Ricerca sul cancro: importante finanziamento per lo IOR – L'Osservatore
Team - Functional Cancer Genomics Lab
Dr. Theurillat on Castration and AR Inhibition in Prostate Cancer
Young Investigator Award – Charles Rodolphe Brupbacher Stiftung
Jean-Philippe P. Theurillat's research works | University of Lugano, Lugano (USI) and other places
Jean-Philippe THEURILLAT | Group Leader | IOR Institute of Oncology Research, Bellinzona | Functional Cancer Genomics | Research profile
Gaston De Bernardis | Swiss Medical Network
9 "Jean Theurillat" profiles | LinkedIn
Better poison dosages for better prostate cancer therapies
CAS-Pr - Certificate of Advanced Studies in Prostate cancer (CAS-Pr)
I medici ticinesi sostengono «con fermezza» il Governo - Ticinonline
One of these mutants is not like the other | Broad Institute
Jean-Philippe THEURILLAT | Group Leader | IOR Institute of Oncology Research, Bellinzona | Functional Cancer Genomics | Research profile
Prostata, ecco perché alcuni tumori accelerano all'improvviso (e altri no)
Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer | Communications Biology
Prostata, ecco perché alcuni tumori accelerano all'improvviso (e altri no)
Movember all'Istituto oncologico di ricerca
Institute of Oncology Research (IOR) su LinkedIn: #biosopenday
Cancro alla prostata: 400 mila franchi a una ricerca ticinese
Mark A. Rubin on X: "Visit their web-based interface for the research to mine the Prostate Cancer Transcriptome Atlas, called the PCaProfiler (https://t.co/J3dWdGdFaq)." / X
Young Investigator Award – Charles Rodolphe Brupbacher Stiftung
Team - Functional Cancer Genomics Lab
